sōlaria biō ads

New Publication Alert! Breakthrough Mechanistic Science from Sōlaria Biō unlocking how the gut–bone axis can slow age-related bone loss I’m thrilled to share brand-new peer-reviewed research from our team at Sōlaria Biō, published in the Journal of Functional Foods. This mechanistic study uncovers how our first-in-class synbiotic medical food, Bōndia™, works inside the body—and why it represents a powerful new approach to preserving bone mass in menopause. -- Why this study matters -- More than half of women over 50 experience osteopenia or osteoporosis, driven by estrogen decline, inflammation, and shifts in the gut microbiome. Traditional interventions often begin after bone loss has already occurred. Earlier this year, we published clinical data in Osteoporosis International showing that Bōndia reduced bone loss by up to 85% in women with osteopenia. Now, this new publication reveals the mechanisms behind those results—the HOW behind the WHAT. -- Key findings -- The study demonstrates that Bōndia™: · Strengthens the gut barrier · Reduces inflammatory immune signaling · Directly suppresses osteoclast activity The publication reflects our commitment to rigorous, transparent R&D—and represents another milestone as we collaborate with leading investigators at Hebrew SeniorLife on the NIH-funded STARS trial, an 18-month study in 220 women age 60+ evaluating Bōndia (SBD111) for long-term bone-loss management. Link to the study: https://lnkd.in/exsyAG2D Link to the press release: https://lnkd.in/er5jP-pG

Did you know? Nearly 70% of women over 50 experience significant decline in bone density. 1 in 2 will suffer a fragility fracture that can change mobility, confidence, independence. At sōlaria biō We believe bone health should be protected long before a first fracture. We believe intervention deserves the same urgency as treatment. Today, on World Osteoporosis Day, we are launching Bondia™, a first-of-its-kind living, plant-sourced synbiotic medical food clinically proven to help protect against bone loss. We are bringing Bondia to the forefront and sharing new clinical evidence. Peer-reviewed results in Osteoporosis International show Bondia™ slowed femoral-neck bone loss by 85% in women with osteopenia. Bondia targets the gut, bone, and immune axis. It calms inflammatory signals that drive bone breakdown. It supports natural bone-building pathways. Bone loss starts early. Screening often comes late. We believe women deserve credible options during the critical years in between. Learn more about how we can help you stay strong at www.solaria.bio https://lnkd.in/edXfckPZ

Listen or watch as our CEO Catherine Balsam-Schwaber sits down with Livelong Media™'s Erin Hunter to discuss the connection between Gut Health & Bone Health Link to watch: https://lnkd.in/eykaZnM8

Bone loss is often framed as a late-life problem. In reality, it begins decades earlier and is driven by more than calcium or strength training. I joined the Livelong Media™ Podcast and Erin Hunter to talk about one of the most overlooked levers in skeletal health and longevity: the gut. We explore how inflammation, immune signaling, and the microbiome influence bone loss, and why women often feel the consequences first, even when they are doing everything “right.” As it turns out bone health is not just about bones. And fractures are not just injuries. They are inflection points for independence, mobility, and aging well. 🎧 Watch the episode here: https://lnkd.in/gCQEcAg2

Thrilled to see this thoughtful review from Dr. Doug Lucas on Bondia, a synbiotic medical food designed to help manage bone loss during menopause. Menopause-related bone loss is a silent but serious health issue, and it’s encouraging to see clinicians engaging with emerging, evidence-based approaches that look toward inflammation, the gut–bone axis, and long-term prevention. If you’re interested in how microbiome science is opening new doors for women’s bone health, this video is well worth a watch: https://lnkd.in/em9ZWm-Y

Why does women’s health still need to go direct-to-consumer? Because too often, women are asked to wait: for referrals, for validation, for options, for answers. At sōlaria biō, we decided not to wait. Bōndia is our first example in bone health, showing an 85% reduction in bone loss for women in osteopenia. Bōndia a medical food built for dietary management. We held it to drug-trial-level rigor: randomized, double-blind, placebo-controlled clinical evaluation over 12 months. This week we had new mechanistic work published in the Journal of Functional Foods, showing Bōndia improved gut barrier integrity, reduced inflammatory immune signaling, and inhibited osteoclast activity - all mechanisms that help explain what has already been observed clinically. Finding new solutions for women's health is about access + education + accountability, while insisting on real evidence. And yes: we’re so confident in what we have built that we take it ourselves and already give it to our moms. Paper: https://lnkd.in/edWCAz2d Moms: https://lnkd.in/eSWyEkYc #bonehealth #womenshealth #team